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ABSTRAK 
 
Tujuan kajian ini adalah untuk mengkaji kesan-kesan kematian sel yang diaruh oleh 
ekstrak minyak pati daripada daun (EO-L) dan kulit kayu pokok (EO-B) G. atroviridis 
terhadap sel-sel kanser otak manusia DBTRG-05MG dan U-87 MG. Kesan anti-
proliferatif EO-L dan EO-B terhadap sel-sel DBTRG-05 MG dan U-87 MG ditentukan 
dengan menggunakan ujian sel pertumbuhan MTT dan diukur melalui pembaca 
mikroplat. Mod kematian sel yang diaruh oleh EO-L ke atas tititsan sel U-87 MG 
ditentukan dengan menggunakan ujian pewarna Annexin-V FITC dan propidium iodida 
dan diukur melalui aliran sitometri. Manakala aktiviti autofagi ditentukan menggunakan 
ujian perencat NVP- BEZ235 dan bacaan diukur menggunakan pembaca mikroplat. 
Kesan EO-L pada potensi membran mitokondria sel U-87 MG pula ditentukan 
menggunakan ujian pewarnaan JC-1 dan pemerhatian dilakukan menggunakan 
mikroskop pendarfluor dan bacaan diukur melalui pembaca mikroplat pendarfluor. 
Berdasarkan keputusan ujian MTT, EO-L menunjukkan potensi perencatan 
pertumbuhan terhadap kedua-dua sel DBTRG-05MG dan U-87 MG berbanding EO-B. 
Aktiviti perencatan pertumbuhan oleh EO-L juga dilihat lebih signifikan pada sel U-87 
MG berbanding sel DBTRG-05MG. EO-L juga mengaruh kematian sel sacara apoptosis 
terhadap sel U-87 MG. Setelah 24 jam sel U-87 MG dirawat, apoptosis telah diaruh 
secara signifikan berbanding sel yang tidak dirawat pada semua kepekatan EO-L. 
Kehilangan potensi terhadap membran mitokondria merupakan indikator awal bagi 
mekanisme kematian sel secara apoptosis. EO-L didapati mengaruh kehilangan 
terhadap potensi membran mitokondria pada sel U-87 MG. Hasil kajian ini mendapati sel 
U-87 MG diwarnakan hijau oleh pewarna JC-1 yang menunjukkan kehilangan potensi 
pada membran mitokondria, dan keputusan ini adalah selari dengan bacaan yang 
diperoleh daripada pembaca mikroplat pendarflour.  Hasil kajian ini juga mendapati 
xii 
 
gabungan rawatan EO-L bersama dengan perencat NVP-BEZ235 berpotensi mengaruh 
kematian sel secara autofagi di dalam sel U-87 MG.  
Kesimpulannya, kajian ini mendapati EO-L berpotensi merencatkan pertumbuhan sel 
kanser otak manusia U-87 MG dengan berupaya mengaruh kehilangan potensi 
membran mitokondria yang akhirnya mendorong kepada kematian sel secara apoptosis 
dan autofagi.  
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ABSTRACT 
 
The aim of this study was to investigate the cell death effects of the essential oils 
extracted from the leaf (EO-L) and stem bark (EO-B) of G. atroviridis on DBTRG-05MG 
and U-87 MG human brain cancer cells. The anti-proliferative effects of EO-L and EO-B 
were determined using MTT assay by microplate reader. The mode of cell death induced 
by EO-L on U-87 MG cell line was determined using Annexin-V FITC and propidium 
iodide staining assay by flow cytometry. Whilst autophagy activity was determined using 
NVP-BEZ235 inhibitor assay by microplate reader. The effect of EO-L on mitochondrial 
membrane potential of U-87 MG cells was determined using JC-1 staining assay by 
fluorescence microscopy and fluorescence microplate reader.  
Based on the MTT assay result, EO-L potentially inhibited both DBTRG-05MG and U-87 
MG cells in comparison to EO-B. The growth inhibition induced by EO-L was significantly 
observed in U-87 MG when compared to DBTRG-05MG cells. The cell death induced by 
EO-L on U-87 MG cells was via apoptosis. At 24 h post-treatment, apoptosis was 
significantly induced in U-87 MG cells treated with EO-L at all concentration tested in 
comparison to the untreated cells. The loss of mitochondrial membrane potential is an 
early indicator for the mechanism of apoptotic cell death. EO-L has induced the loss of 
mitochondrial membrane potential in U-87 MG cells. The findings herein showed that U-
87 MG cells were stained with JC-1 green fluorescence, which indicated the loss of 
mitochondrial membrane potential, and this observation was correlated with the readings 
obtained by fluorescence microplate reader. This study also found that co-treatment of 
EO-L and NVP- BEZ235 inhibitor potently induced the autophagic cell death in U87 
cells.  
xiv 
 
In conclusion, EO-L potently inhibited the growth of U-87 MG human brain cancer cells, 
by inducing the loss of mitochondrial membrane potential which ultimately leads to the 
apoptotic and autophagic cell death 
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. CHAPTER 1 
INTRODUCTION 
 
1.1 Epidemiology of Brain Tumor/Cancer 
One of the leading causes to brain cancer is brain tumor and brain metastases. 
Brain tumors are among the most serious and complicated disease in comparison to 
other cancer diseases like lung cancer, breast cancer and skin cancer (Teplyuk et 
al., 2012). The primary tumor of the central nervous system is glioma. Treatment 
such as standard chemotherapy and other types of therapy could not totally cure or 
inhibit the proliferation of the glioma cells (Zülch, 2013).  
 
1.2 Histology and Molecular Genetics of Brain Tumors Types. 
Initiation of  brain cancer in the glioblastoma (GBM) cells is either through gene 
mutation or DNA damage when compared to the other types of brain cells such as 
meningiomas, medulloblastomas, ganglioglioma, schwannomas and chordomas 
(Cohen-Inbar and Sheehan, 2016). Despite the many advances in tumor treatments, 
only a small percentage of GBM patients are fully cured. The high invasiveness of 
GBM cells causes complications to the surgical treatment, chemotherapy and 
radiotherapy. Furthermore, an abnormality in apoptosis as well as cancer stem cells 
may contribute to chemo resistance as well (Wong, 2011).  
 
1.3 Natural Products Derived from Plant as an Alternative Treatment for Cancer. 
Naturally-derived bioactive compounds from plants had showed potential treatment 
in inhibition of the growth of the glioma cells in addition to synthetic drugs. Plants 
have been reported as an alternative therapy in curing cancers as a result of their 
anti-proliferative and anti-fungal properties (Wang et al., 2012). In this study, 
essential oils from the leaf and bark of Garcinia atroviridis (G. atroviridis) were used 
in determining their cytotoxic property. Flavonoids and 4-methylhydroatrovirinone 
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are among the phytochemicals of the plants, G. atroviridis present in the plant which 
has anti-inflammatory effect (Tan et al., 2013). However, its cytotoxic activity against 
cancer has yet to be affirmed. Hence, this is the first study to investigate and report 
the cytotoxic effects of G. atroviridis against the brain cancer cells. Two model of 
GBM cells were used in this study, namely DBTRG-05MG and U-87MG. 
Assessments on the cell death effects of essential oils extracted from the leaf (EO-
L) and stem bark (EO-B) of G. atroviridis were examined and investigated using 
several number of in vitro analyses, including anti-proliferative study using MTT 
reagent, the mode of cell death via apoptosis or necrosis using Annexin-V FITC and 
propidium iodide staining assay, mitochondrial membrane potential using JC-1 
assay and autophagy by using inhibitor assay. 
 
1.4 Objectives. 
Main objective 
To investigate the cell death effects of G. atroviridis extracts on DBTRG-05MG and 
U-87MG human brain cancer cells. 
 
Specific objectives 
The essential oils extracted from the leaf (EO-L) and stem bark (EO-B) of G. 
atroviridis were used to treat DTBRG-05MG and U-87MG cell lines. The following in 
vitro assays as listed below were conducted:  
1. To determine the anti-proliferative effects of EO-L and EO-B on DBTRG-
05MG and U-87MG cells using (MTT) assay by microplate reader 
2. To determine the mode of cell death induced by EO-L on U-87MG cells 
using Annexin-V FITC and propidium iodide staining assay by flow cytometry 
3. To investigate the cell death effect of EO-L on mitochondrial membrane 
potential of U-87MG cells using JC-1 staining assay by fluorescence 
microscopy and fluorescence microplate reader 
3 
 
4. To determine the cell death effect of EO-L on autophagy activity in U-87MG 
cells using inhibitor assay by microplate reader 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Brain Tumor 
An abnormal growth of cells in the brain tissues can lead to a brain tumor. Brain 
tumors can be either benign without metastatic or malignant with cancer cells that is 
actively growing and invading the adjacent tissue (Tarin, 2012). In the brain, primary 
brain tumors can be formed and it can be metastasized to other parts of the human 
organs.  
 
2.2 Stages of Brain Cancer. 
Brain tumors are not categorized in the same group of disease although it derives 
from the same type of brain tissue. Tumors stages are dependent on how the cells 
in the tumor appear microscopically.  
 
The primary brain tumors are from gliomas, meningiomas, pituitary 
adenomas, vestibular schwannomas and medulloblastomas. Glioma is segregated 
into four types which are astrocytomas, oligodendrogliomas, ependymomas, and 
choroid plexus papillomas (Chen et al., 2010). However, even benign tumors can 
cause serious problems if they propagate which may cause intracranial dysfunction 
(DeAngelis and Posner, 2008).  
 
Brain cancers severity depends on their cell type and grade. However, it rarely 
spread to other organs in comparison to other types of cancer such as breast 
or lung cancer. Both cancers can be detected according to TMN staging, cancer 
staging notation system that describes the stage of the cancer which the letter 
represent as T (Tumors), N (nodes) and M (metastasis) that can detect the location 
and spread of cancer cells (Edge and Compton, 2010).  
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U-87 is a human primary glioblastoma cell line formally known as U-87 (Uppsala 
87). These cells arise from the brain (glioblastoma astrocytoma) and can cause 
tumor in the brain (Jaszberenyi et al., 2013). DBTRG-05MG (Denver Brain Tumor 
Research Group 05 Malignant Glioma)  cell line is a malignant glioma cell which can 
caused tumor in the brain from the  anaplastic astrocytoma (Ali et al., 2011). 
 
 
                                                                                
 
Figure 2.2.1 shows the U-87MG cell line morphology observed under inverted 
microscope with magnification of 10 X.      
                               
                                      
                                                                                 
 
Figure 2.2.2 shows the DBTRG-05MG cell line morphology observed under inverted 
microscope with magnification of 10 X                                                                                                                                     
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2.3 Metastatic Brain Cancer 
Cancer cells which developed in the body organ such as the breast can spread in 
the body system such as the bloodstream as well as to the brain. Tumors formed by 
such cancer cells metastasize to other the organs are called metastatic tumors. 
Metastatic brain cancer is a mass of cells that derived from other body organ which 
then spread into the brain (Roy and Bandyopadhyay, 2012). Metastatic tumors in 
the brain are more common than primary brain tumors (Chaffer and Weinberg, 
2011). 
 
2.4 Factors Lead to Brain Cancer 
People exposed hazards are more likely to develop brain cancer. Individuals with 
higher risk to obtain brain cancer are those who work in an oil refinery, aircraft 
company and rubber-industry in comparison to the non-industrial. Furthermore, 
others factors have been suggested to cause brain cancer such as head injury, 
pesticides, smoking, radiation and viral infection however an extensive should be 
carried out to further confirm the risk factors (Baldi and Loiseau, 2012). In addition, 
International Agency for Research on Cancer (IARC) stated that usage of mobile 
phones may also increase in initiating the formation of gliomas to human. The IARC 
classified cell phones as group 2b carcinogens (possibly carcinogenic) however, 
further investigation should also be carried out to validate this hypothesis.  
 
2.5 Treatment of brain cancer. 
Many factors such as age, health, medical history, tumor diagnosis, allergy to  any 
medications or treatment are important factor to cause brain tumors (DeSantis et al., 
2014). Next, grade I and II of tumors are treated by closed monitoring or surgery. 
But, grade II tumors are observed more closely after surgery to make sure there is 
no relapse. Grade tumors of grade III and IV are malignant and difficult to remove 
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and require complicated treatments such as radiation and chemotherapy because 
the tumor cells still can grow back.  
 
2.6 Types of Cell Death 
A balanced homeostasis in the body is a crucial factor in avoiding development of 
cancer cells. Thus, activation of cell death mechanism is vital in maintaining the 
homeostasis of proliferative of healthy and normal cells (Walter and Ron, 2011). Cell 
death can be occurred in cancer cells to those individuals who undergo 
chemotherapy and radiotherapy (Ouyang et al., 2012). Cell death consists of two 
types which are typical cell death (apoptotic, autophagy, necrosis and cornification) 
and atypical cell death (mitotic catastrophe, pyronecrosis and anoikis). Both modes 
of cell death may involve in the mechanism of apoptotic, autophagy or mitotic 
catastrophe properties in the cells (Wlodkowic et al., 2011). 
 
2.6.1 Apoptosis 
A structured or programmed process of cell death is known as apoptosis  when 
changes occurs in the cell or when the cells induced by either physiological or 
pharmacological agents (Wong, 2011). The cell morphology changes include 
nuclear fragmentation and blebbing of plasma membrane. The apoptotic cells will be 
engulf by macrophages through the phagocytosis process (Underhill and 
Goodridge, 2012) . 
 
2.6.2 Autophagy Cell Death 
It is a programmed self-degradative process which is important for balancing 
sources of energy in development and in response to nutrient stress. Autophagy 
also plays a role in removing misfolded or aggregated proteins, clearing damaged 
organelles and removing intracellular pathogens. Autophagy  promotes cellular 
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senescence, act as cell surface antigen, protects against genome instability and 
prevents cell damage (Ouyang et al., 2012). 
 
2.6.3 Necrosis  
Unprogrammed type of cell death mode is called necrosis which can cause injury 
and induce inflammation to the cell. It causes morphological changes to the cells by 
bursting the cell content and organelles (Chen et al., 2014). Therefore, it does not 
follow the apoptotic signal transduction pathway and results in the uncontrollable 
release of products of cell death into the extracellular space. This will trigger the 
inflammatory response to the damage area and adjacent tissues compartment 
(Green et al., 2011). 
 
2.7 Sustaining Proliferative Signaling 
Tumors are masses of highly proliferative cells or known as cancer cells. Cancer 
cells have a unique ability to sustain chronic proliferation. In normal cells, they can 
control the production and release of growth-promoting signals and provide 
homeostasis in the cells. But in cancer cells, they interrupt the function and 
mechanism pathway of normal cells (Hanahan and Weinberg, 2011). 
 
2.8 The Mechanism of Apoptosis 
Apoptosis aids in maintaining the balance between cell proliferation and cell death. 
There are two types of apoptotic pathways which are the extrinsic pathway and the 
intrinsic pathway (Schlossmacher et al., 2011). Cancer is one of the consequences 
of defective in apoptosis mechanism which lead to the formation of proliferative of 
malignant cells. The mechanism of apoptosis is complicated by many pathways 
however any interruption along the pathways will lead to malignant transformation 
as well as resistance to chemotherapy drugs. Nevertheless, apoptosis plays an 
important role in the treatment of cancer. Mechanism of apoptosis depend on the 
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stimuli received such as stress, inhibitor of cyclin dependent kinase and p53 
pathway (Vurusaner et al., 2012). 
 
2.9 Essential oils and their bio-activities 
Essential oil extracted from plants have been used in perfume industry, processed 
food preservative and flavoring in drinks for many years (Gautam et al., 
2014).  Moreover, the phytochemicals found in plants can be extracted from various 
parts of plants such as in flowers, leaves, fruits and barks (Krishnaiah et al., 2011). 
Recently, plant essential oils play an important role in cancer treatment as an 
alternative medicine and natural therapies. The essential oil has potential 
therapeutic benefits because it contains many natural antioxidant phytochemicals 
such as phenols, flavonoids and tannins which are potent to kill cancer cell 
(Doughari, 2012). Many research had shown that essential oil from plants contain 
high antioxidant, act as detoxifying agent as well as anti-inflammatory (Zhang et al., 
2011). 
 
An antioxidant can be referred to any entities that interrupt the oxidative damage to 
a target molecule. The antioxidant is able to scavenge the free radical with the help 
of the natural (plants) or synthetic antioxidants (Halliwell and Gutteridge, 2015). The 
natural antioxidants are safer and are without any side effects.  
 
G. atroviridis also known as “Asam Gelugur”, “Asam gelugo” or “Asam keeping” in 
Malay. The sundried slices of the fruits from this plant are used for culinary 
purposes and as traditional medicine (Aiemsaard and Punareewattana, 2017). In 
previous study, Garcineflavanone and Garcineflavonol were isolated from G. 
atroviridis have been used to cure the Alzheimer’s disease (Tan et al., 2013).  
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The total volatiles obtained by hydrodistillation of the fruit of G. atroviridis have 
showed stronger activity against Gram-positive bacteria and selective inhibitory 
activity against COX-2 (Tan et al., 2013). But, the cytotoxicity analyses of essential 
oils obtained from G. atroviridis is yet not to be determined. Thus, this study aims to 
investigate the potential role of total volatiles of G. atroviridis in inducing the death in 
DBTRG-05MG and U-87MG human brain cancer cell line by modulating the 
activities of apoptosis and autophagy in vitro. 
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CHAPTER 3 
METHODOLOGY 
 
3.1 Materials and Chemicals 
3.1.1 Chemicals and Reagents 
All chemicals and reagents used in this study are listed in Table 3.1 
 
Table 3.1: List of chemicals and reagents 
 
Chemicals and reagents Supplier 
5,5’,6,6’-tetrachloro-1,1’,3,3’-tetraethyl-
benzamidazolocarbocyanin iodide (JC-1) dye 
Invitrogen, USA 
Dimethyl sulphoxide (DMSO) Sigma-Aldrich, USA 
Distilled water Merck, Germany 
Accutase TM Solution  Millipore, USA 
Trypsin  Millipore, USA 
5-diphenyltetrazolium bromide dye (MTT) Merck, Germany 
Dulbecco Modified Eagle’s Medium (DMEM) GIBCO BRL, UK 
Ethanol (95% v/v) Merck, Germany 
Fetal bovine serum (FBS) GIBCO BRL, UK 
Trypan blue Sigma-Aldrich, USA 
Penicillin Streptomycin Glutamine (100X) Gibco BRL, UK 
Phosphate buffered saline (PBS) Amresco, USA 
Tamoxifen Citrate Salt Nacalai tesque, Japan 
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3.1.2 Consumables. 
All consumables used in this study are listed in Table 3.2 
 
Table 3.2: List of consumables. 
 
Consumables Supplier 
96-well micro-titer plates Nunc, Denmark 
Chamber slides Becton Dickson, USA 
Cover slips (Menzel-Glaser) Deckglaser, Germany 
Cryogenic vials and Cryoboxes Nalgene, USA 
Luer-Lok™ Syringes (25 ml and 50 ml) and   
sterilised –filter 0.22 µm 
BD Plastipak™, Spain 
 
Micropipette tips (10 µl, 100 µl, 200 µl and 1000 µl) Axygen® Scientific, USA 
Microscope slides Sail Brand, China 
Serological pipettes (10 ml and 25 ml) Nunc, Denmark 
Syringe membrane filter (0.22 µm) Milipore, UK 
Tissue culture flasks (25 cm2 and 75 cm2) Becton Dickinson™, USA 
 
3.1.3 Kits 
All kits used in this study are listed in Table 3.3 
 
Table 3.3: List of kits 
 
Kits Supplier 
Annexin-V-FLUOS Detection Kit Roche, Germany 
  PI3K inhibitor kit    Roche, Germany 
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3.1.4 Laboratory Equipment 
All of laboratory equipment used in this study are listed in Table 3.4 
 
Table 3.4: List of laboratory equipment 
 
Name and Brand Supplier 
Airstream Class II Biohazard Safety cabinet Nuaire, USA 
Cell counter (Tagoshi RS-4) Soon Hoong Seng PTE LTD, 
Singapore 
Centrifuge 5415R Eppendorf, Germany 
Centrifuge 5810R Eppendorf, Germany 
Flow cytometer (FACS Calibur) Becton Dickinson, USA 
Fluorescence Microscope Nikkon, Japan 
Haemacytometer (Neubauer Improved) LO-laboroptik Ltd., UK 
  Incubator (Binder) Thermo Scientific Fisher, 
USA 
Inverted microscope (OLYMPUS CKX41) OLYMPUS, USA 
Microcentrifuge (Minispin plus) Eppendorf, USA 
Microplate Reader (Versamax) Molecular Devices, USA 
Vortex mixer (MSI) IKA, Germany 
Water bath (Memmert) Camlab, UK 
 
 
3.1.5 Isolation of Essential Oils 
Stem bark and leaf of G. atroviridis were bought from Herbagus Trading, Kepala 
Batas, Pulau Pinang. A voucher specimen (USM 11201) has been deposited with 
the herbarium of Universiti Sains Malaysia, Penang, Malaysia. The dried stem bark 
collected of G. atroviridis was grinded into powder and the leaves were washed with 
distilled water and cut into small pieces prior to hydrodistillation. The hydrodistillation 
was carried out for 5 h using a Clevenger-type apparatus. The extracts were 
carefully concentrated using a gentle stream of nitrogen gas at room temperature, 
yielding pale yellow oils. The oils isolated from leaf (EO-L) and barks (EO-B) were 
kept at 4 °C until analysis. A stock concentration of 10 000 µg/ml was prepared by 
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dissolving the oils in dimethyl sulphoxide (DMSO) and kept at -20 °C until use. Both 
EO-L and EO-B were diluted in an appropriate growth culture medium before use. 
The final concentration of DMSO in the medium was less than 0.1 % (v/v). 
 
3.2 Cell Culture 
3.2.1 Human Brain Cancer Cell Lines 
Two types of brain cancer cell lines were used throughout this study.  
a) DBTRG-05MG (Denver Brain Tumor Research Group 05 Malignant Glioma) 
b) U-87MG (Upssala 87 Malignant Glioma) 
 
Both cell lines were obtained from by Dr. Agustine Nengsih from Department of 
Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia (PPSP, 
USM). Both cells were originally purchased from the American Type Culture 
Collection (ATCC) (Rockville, USA). These cells were grown in suitable condition 
and the medium was changed every 2 days. All cell handling and medium 
preparation was carried out using aseptic technique in class II safety cabinet. 
 
3.2.2 Reagents for Cell Culture Work 
3.2.2.1 Medium 
The growth medium used in this study was Dulbecco Modified Eagle’s Media 
(DMEM) (Gibco BRL, UK) for both cell lines and stored at 4 oC. The reagents were 
thawed before used and filtered-sterilised with 0.22 µm disposable filter units. 
 
3.2.2.2 Heat-inactivated Fetal Bovine Serum (FBS) 
A bottle of FBS (Gibco BRL, UK) (100ml) was stored at -20 °C. The serum was 
filtered-sterilised with 0.22 µm disposable filter units and aliquoted into sterile 15 ml 
tubes and kept at -20 oC. The FBS was thawed in water bath at 37 oC prior to use. 
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3.2.2.3 Phosphate-Buffered Saline (PBS) 
Ten times Phosphate-buffered saline (PBS) (Gibco BRL, UK) was filtered-sterilised 
with 0.22 µm disposable filter units and aliquoted into 50 ml Falcon tube with 
distilled water added to produce 1x working concentration. The PBS was stored at 
room temperature. 
 
3.2.2.4 Penicilin/Streptomycin (PenStrep) Antibiotics Solution. 
A bottle of ready-made containing penicilin/streptomycin (PenStrep) solution of 10 
mg/ml (Gibco BRL, UK) was filtered-sterilised with 0.22 µm disposable filter units 
and aliquoted into sterile 15 ml tubes before being stored at -20 °C. The antibiotic 
was thawed prior use at 37 °C in the water bath. 
 
3.2.2.5 Complete Growth Medium. 
A complete growth medium was used in this study to culture and maintain the cell 
lines. The medium consists of Dulbecco’s Modified Eagle’s Medium (DMEM) 
solution supplemented with 10 % (v/v) FBS and 1 % (v/v) of PenStrep. The 50 ml 
medium was prepared by adding 5 ml FBS, 50 µl of PenStrep and 45 ml of DMEM 
media. All prepared media were kept at 4 °C and thawed before used. 
 
3.2.2.6 Trypsin (0.25 %, w/v)/EDTA (0.03 %, w/v) Solution. 
A ready- made Trysin of 0.25 %, EDTA 0.03% (Gibco BRL, UK) was filter-sterilised, 
aliquoted and stored at - 20 °C until use. The trypsin was thawed in 37 °C prior to 
use. 
 
3.2.2.7 Cryogenic Medium 
The medium contained 10 % Dimethyl sulphoxide (DMSO) in FBS was prepared 
and used to store ampoules of cells in -80 °C storage or liquid nitrogen. The 
cryogenic medium was prepared fresh and kept cold prior to use.  
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3.2.3 Culture Procedures and Conditions 
 
All tissue culture procedures were carried out in sterile conditions (Class ll biohazard 
cabinet) using aseptic techniques to avoid any contamination. Cells were cultured in 
growth medium and maintained in a humidified incubator at 37 °C in an atmosphere 
of 5 % CO2 and 95 % air. 
 
 
3.2.4 Thawing of Cells from Frozen Storage 
 
The frozen cells was retrieved from the -80 °C storage and thawed at room 
temperature for 5 minutes. The entire frozen cells were gently pipetted into a 15 ml 
centrifuge tube containing 4 ml of complete growth medium. The content was 
centrifuged at 1000 rpm for 5 minutes to remove the DMSO. The supernatant was 
aspirated and 2 ml of PBS was then added and re-suspended to wash the cell 
pellet. The cell pellet was re-centrifuged at 1000 rpm for 5 minutes to make sure 
DMSO residue or any debris was completely discarded. The cell pellet was then re-
suspendered in 1-2 ml of complete growth media. The cell suspension was then 
slowly pipetted into a 25-cm2 tissue culture flask containing 4-5 ml of culture media. 
The cell morphology was observed using an inverted phase contrast microscope to 
check for cell viability. The culture flask was incubated in a humidified atmosphere 
containing 5 % CO2 at 37 °C. The growth medium was replaced every 2-3 days. 
 
3.2.5 Sub-Culturing of Cells 
The cells were sub-cultured into a new flask when they reached about 70-80 % 
confluency in the flask to avoid nutritional deficiency and microbial contaminants. 
The old medium from the flask were discarded and cells were rinsed with 2 ml PBS. 
After that, the PBS was discarded and 1 ml trypsin-EDTA solution was added into 
the flask. The flask was left for about 5 min in the CO2 incubator for allowing the 
adherent cells to detach from the surface of flask. The flask was gently tapped to 
ensure complete cells detachment and the process was followed by observing the 
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flask using the inverted microscope. Then, 1 ml of fresh culture medium was added 
into the flask to inactivate the trypsin activity. The medium (containing the cells) was 
aspirated and transferred into a sterile 15 ml centrifuge tube. The tube was 
centrifuged at 1000 rpm for 5 min. The supernatant was then removed and the cell 
pellet was re-suspended in 1 ml growth medium. The mixture containing cells was 
aspirated and dispensed at a 1:4 dilution (normally into 4-5 flasks). The medium 
volume in each new 75-cm2 flask was made up to 7-10 ml by adding fresh growth 
media and the cultures were incubated in humidified atmosphere containing 5 % 
CO2 at 37 °C. 
 
3.2.6 Cell Counting for Seeding 
The number of viable cell was counted using Equation 1: 
Number of viable cell/ml =
A × dilution factor × 104
4
 
A = Total of unstained cell in the calculated grid 
 
3.3 Assessment of Cell Viability using (MTT) Assay  
Cell proliferation was determined using following formula as noted in Equation 2:  
𝑂. 𝐷. 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 − 𝑂. 𝐷. 𝑏𝑙𝑎𝑛𝑘
𝑂. 𝐷. 𝑢𝑛𝑡𝑟𝑒𝑎𝑡𝑒𝑑 𝑐𝑒𝑙𝑙 −   𝑂. 𝐷. 𝑏𝑙𝑎𝑛𝑘
× 100 % 
 
DBTRG-05MG and U-87MG were grown in complete medium. DBTRG-05MG and 
U-87MG cells were seeded at density of 5 x 103 per well and is incubated overnight 
for the cells to adhere. All cells were cultured at 37 °C in a humidified condition with 
5% CO2. Cells were treated with either essential oil isolated from leaf (EO-L) or bark 
(EO-B) of G. atroviridis. The concentrations of EO-L or EO-B used in this study were 
25, 50, 75 and 100 µg/ml. Tamoxifen at 35 µM of concentration was used as 
positive control in this study. At each time point of 24h, 48h and 72h, 10 µl (5 mg/ml) 
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of MTT reagent (Merck Millipore, USA) was added to each well and the plate was 
incubated for 4 hours at 37 °C. The medium containing MTT solution was discarded 
from each well and 100 µl of DMSO was added. The absorbance at 570 nm was 
measured by microplate reader. The dose response effect and IC50 value of G. 
atroviridis was calculated using formula listed in Equation 2 based on the 
absorbance reading obtained at time point of 24 h, 48 h and 72 h. 
 
3.4 Apoptosis Detection  
 
Apoptosis was detected using the Annexin-V FLUOS Detection Kit (Roche, 
Germany). The two-stain kit containing Annexin-V-fluorescein antibody and 
propidium iodidie (PI) dye was used to determine the mode of cell death induced by 
the agent. 
 
The phosphatidylserine (PS) on the outer leaflet of apoptotic cell-membranes was 
detected using Annexin-V FITC which emitted green fluorescence with wavelength 
of excitation/emission = 488/518 nm whereas PI staining enters the plasma 
membrane of the necrotic dead cells which emitting red fluorescence wavelength of 
excitation/emission = 488/617 nm.  
 
3.4.1 Preparation of Annexin-V Staining Solution 
Staining solution was ready-to-use for Annexin-V-fluorescein labelling reagent and 
PI which were provided by the manufacturer (Roche, Germany).  
 
3.4.2 Treatment of Cells 
EO-L or EO-B at increasing concentrations with positive and negative controls were 
also included in the assay and cells were incubated with all treatments for 24 h, 48 h 
and 72 h. Following incubation, the cells were then observed under microscope and 
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further analysed for apoptosis detection by fluorescence microscopy and flow 
cytometry. 
 
3.4.3 Detection of Apoptosis by Flow Cytometry 
For flow cytometric analysis, the floating cells were collected in 15 ml tubes and 
adherent cells were detached as by using Accutase (Millipore, USA). Both floating 
and adherent cells were pelleted by centrifugation at 300 x g for 2 min. The 
supernatant was then removed and 1 ml of PBS was added to wash the cells. The 
cells were centrifuged 300 x g for 2 min and PBS was discarded. This step was 
repeated twice. The cell pellet was re-suspended in 1ml of incubation buffer and 
transferred out 100 µl of the mixture into Falcon round bottom tube. Then, 2 µl of the 
two-stain kit were added in each flow tube and incubated at room temperature with 
no light for 10 min. Following incubation, 400 µl incubation buffer was added to each 
flow tube before the cells were analysed using the FACSCalibur (Becton Dickinson, 
USA). 
 
For flow cytometric analysis, 10 000 cells per sample were acquired and analysed 
with CELLQuest Pro Software (USA).  The percentage of apoptotic cells (total late 
apoptosis + total early apoptosis) was calculated based on the quadrant readings. 
 
3.5 Analysis of Mitochondrial Membrane Potential (∆ψm) 
An early feature of apoptosis is via depolarization of the mitochondrial membrane 
potential (ΔΨm). Loss of the ΔΨ can be detected using 5,5’,6,6’-tetrachloro-
1,1’,3,3’-tetraethyl- benzamidazolocarbocyanin iodide (JC-1) dye. In this study, the 
effect of EO-L (25-100 µg/ml) in U-87MG cells was investigated using JC-1 dye by 
which the qualitatively observed by fluorescence microscopy and quantitatively 
measured by fluorescence   microplate reader. Both positive and negative controls 
were also included in the assay. The ∆ψm is indicated by a decrease in the 
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red/green fluorescence intensity ratio, where the red fluorescence represents the J-
aggregates (high ∆ψ), while the green fluorescence represents the monomer (low 
∆ψ). Knowledge of the ΔΨ and how it changes during apoptosis may help to clarify 
the actions of EO-L on the ΔΨm of U-87MG cells. 
 
3.5.1 Preparation of JC-1 Dye and Assay Buffer 
 
JC-1 was supplied in liquid form (Invitrogen, USA). The dye was aliquoted and kept 
at -20 °C, protected from light according to the manufacturer’s guideline. One table 
of Cell-Based Assay Buffer was diluted in 100 ml distilled water and the mixture can 
be kept for one year at room temperature. 
 
3.5.2 Preparation of Working Solution 
A working solution of JC-1 dye was freshly prepared prior use where a stock 
solution was diluted in ratio 1:10. The solution was mixed thoroughly to avoid 
precipitation of the JC-1 dye and it was protected from light. The JC-1 Working 
solution was immediately used for staining the cells. 
 
3.5.3 Detection of Alterations in ΔΨm using JC-1 Dye by Fluorescence Microscopy. 
U-87MG cells were seeded in a 96-well plate with cell density of 1x 105 cells/ml. The 
cells were cultured in a CO2 incubator overnight at 37 °C. The cells were exposed to 
different concentrations of EO-L for 24 h to 72 h of incubation periods. The JC-1 
Staining Solution was added to each well of the plate. Then, the sample was 
incubated in CO2 incubator at 37 °C for 15 min. The plate was carefully centrifuged 
at 400 x g and then the supernatant was aspirated from each well. Next, 200 µl of 
Assay Buffer was added to each well in the plate. The supernatant was removed 
and 200 µl of Assay Buffer was added again at each well of the plate and this step 
was repeated one more time. The supernatant was discarded again and added 100 
µl of Assay Buffer. The cells were observed under the fluorescence microscopy. 
